Keywords: argenta, swings, l8, 9m, profit, fy, uk-based
Argenta swings to L8.9M profit in FY 2007
Article | 10 September 2007
UK-based drug development firm Argenta Discovery's total revenue for the year ended March 31, 2007, was L23.5 million ($46.0 million), representing 270% growth over ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
